Chester County News and Community Website
WAYNE, PA — A peer-reviewed study of Cagent Vascular’s Serranator catheter reported high procedural success and wound-healing rates in patients with chronic limb-threatening ischemia, findings that arrive as new reimbursement …
Cagent Study Shows Strong Outcomes in High-Risk Limb Cases Read More
PHILADELPHIA, PA — iECURE announced that new clinical data from its ongoing OTC-HOPE trial evaluating ECUR-506 in neonatal-onset ornithine transcarbamylase deficiency will be presented this month at two medical conferences.
iECURE Reports Early OTC Gene Therapy Trial Results Read More
PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) reported additional Phase 2 trial data showing a dose-response relationship for its SkinJect treatment candidate for nodular basal cell carcinoma, with the …
Medicus Pharma Reports Expanded Phase 2 Skin Cancer Trial Data Read More
MALVERN, PA — YPrime launched an AI-powered calculation engine within its eCOA platform to automate how clinical trial data calculations are configured and executed, aiming to reduce manual processes and …
YPrime Launches AI Calculation Engine for Clinical Trial Platform Read More
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) recently published results from a Phase 2/3 clinical trial evaluating its investigational drug buntanetap in patients with mild to moderate Alzheimer’s disease, …
Annovis Bio Publishes Phase 2/3 Alzheimer’s Trial Results Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (Nasdaq: ACRS) reported full results from a Phase 1a clinical trial of its ATI-052 antibody and outlined plans to advance multiple programs, including selecting …
Aclaris Reports Phase 1a Results for ATI-052, Advances Pipeline Read More WASHINGTON, D.C. — Federal regulators are moving to speed up drug development by launching real-time clinical trials that allow safety data and results to be reviewed as studies are underway …
FDA Pushes Faster Drug Approvals With Real-Time Trials Read More
WILMINGTON, DE — Incyte (Nasdaq: INCY) will present full results from a Phase 3 study of tafasitamab for first-line diffuse large B-cell lymphoma at the American Society of Clinical Oncology …
Incyte to Present Phase 3 Tafasitamab Data at ASCO Meeting Read More
WILMINGTON, DE — AstraZeneca reported that its experimental drug tozorakimab reduced moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease in a Phase III trial.
AstraZeneca Drug Reduces COPD Exacerbations in Phase III Trial Read More
HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) recently reported new Phase 3 data showing sustained symptom improvement and reduced antibody levels in patients with generalized myasthenia gravis treated with …
Johnson & Johnson Reports Long-Term Data on Myasthenia Drug Read More